SpeeDx are featured in a great article in GenomeWeb discussing Mycoplasma genitalium, and the antibiotic resistance status of this significant sexually transmitted...
The establishment of a European subsidiary company, SpeeDx Limited, headquartered in the London Bioscience Innovation Centre, will support the future...
– Goffin’s distribution channels will allow broader availability and accessibility of SpeeDx diagnostics in the Benelux market –
SYDNEY, AUSTRALIA–(March 21,...
Austrade’s Success Stories article highlights our focus in tackling the growing threat of antimicrobial resistance using precision medicine. SpeeDx develops...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Cookie policy
